Lexington Biosciences Inc. (LXGTF)

[Door2Door]

That would explain the fact why 99% of us have never had an endothelial checkup at our doctors office. In spite of the fact that it could mitigate the 50% of heart attacks which currently have no warning signs before the actual attack. Current diagnostics to predict cardiovascular disease and stroke are either way to inaccurate or too expensive and impractical for frequently use. LXGTF will change all that imo.